Data belonging to: "Cross-resistance between Platinum-based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer"

DOI

These data support the findings described in "Cross-resistance between Platinum-based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer" by Slootbeek et al. All data traceable to patients (eg. Study ID, date of birth) is excluded from the dataset.The dataset contains response data of 28 metastatic castration-resistant prostate cancer patients who recieved both a platinum-based chemotherapy and a PARP inhibitor. For conclusions and interpretations, please see the paper.

Date Submitted: 2022-12-19

Identifier
DOI https://doi.org/10.17026/dans-2x5-cngv
Metadata Access https://lifesciences.datastations.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.17026/dans-2x5-cngv
Provenance
Creator P.H.J. Slootbeek (ORCID: 0000-0002-5635-919X)
Publisher DANS Data Station Life Sciences
Contributor P.H.J. Slootbeek; N. Mehra (Radboud university medical center (Radboudumc))
Publication Year 2023
Rights DANS Licence; info:eu-repo/semantics/restrictedAccess; https://doi.org/10.17026/fp39-0x58
OpenAccess false
Contact P.H.J. Slootbeek (Radboudumc)
Representation
Resource Type Dataset
Format text/csv; application/zip
Size 10105; 14054
Version 1.0
Discipline Life Sciences; Medicine